Capital ® Q Ventures Announces Strategic Investment in NUR to Support Category Launch
NUR is rethinking how protein fits into everyday life.”
ORLANDO, FL, UNITED STATES, April 10, 2026 /EINPresswire.com/ -- Capital Q® Ventures announces a strategic investment in NUR, a nutrition company redefining protein through high-absorption formats designed for daily hydration. The investment comes as NUR launches its growth capital raise to scale production and expand distribution of its clear protein water-mix.— Diego Rivero, Deal Team Lead at Capital Q® Ventures
NUR utilizes fermented Beta-Lactoglobulin (BLG), the primary protein found in whey and one of the highest-quality protein sources available. Compared to traditional whey proteins, BLG is richer in essential amino acids, particularly leucine, which plays a key role in muscle protein synthesis. Designed for high solubility and efficient absorption, NUR delivers a complete protein in a light, hydration-based format that integrates seamlessly
into daily routines.
“NUR is rethinking how protein fits into everyday life,” said Diego Rivero, Deal Team Lead at Capital Q® Ventures. “They’re not competing with traditional supplements, they’re building a new category around hydration, absorption, and repeat use. That shift aligns closely with where consumer demand is moving.”
NUR’s growth is currently driven by Amazon and direct-to-consumer channels, where the company is seeing strong early traction and repeat purchase behavior. In parallel, targeted activations across fitness and wellness communities, including Equinox, Pvolve, and Soho House, are driving trial and reinforcing high-conversion usage moments.
Looking ahead, the company plans to expand into regional retail through high-velocity specialty accounts such as Erewhon, with a path toward broader national distribution. NUR is also exploring opportunities within the medical and wellness ecosystem, supported by macro tailwinds including GLP-1 adoption, digestive health awareness, and increased focus on protein quality.
The company is led by Co-CEOs Lucy Geppert, who brings a background in restructuring and operational scaling, and Carolin Springborn, who leads brand, product, and consumer insight, driving NUR’s focus on redefining how protein fits into everyday life.
About Capital Q® Ventures Inc.
Founded in 2017, Capital Q® Ventures Inc. is a Florida-based firm specializing in alternative investments through its Full-Stack and Tri-Party Venture Funds®. The firm provides financing and operational support via the Capital Q Velocity platform, focusing on building and scaling emerging companies to deliver risk-adjusted performance.
About NUR
NUR is a nutrition brand focused on “protein as hydration.” The company develops clear, high-absorption protein mixes designed for use in standard water bottles, offering a clean-label alternative to traditional powder-based supplements.
Will Wellons
Wellons Communications
+1 407-339-0879
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
